PMN

ProMIS Neurosciences

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 1

Sell signal 1

consensus rating "Strong Buy"

EPS Below Expectations

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About PMN

Promis Neurosciences Inc.

A company that developing therapeutics for alzheimer's, amyotrophic lateral sclerosis, and parkinson's disease

Industry

Biological Technology

Established Date

01/23/2004

Listing Date

07/08/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.promisneurosciences.com

Security Type

Common stock

Office address

Suite 200, 1920 Yonge Street , Toronto, Ontario , M4S 3E2

Business

Introduction

ProMIS Neurosciences Inc., incorporated on January 23, 2004 under the Canadian Business Corporations Act, is located at 1920 Yonge Street, Toronto, Ontario. The company is applying its patented technology platform to build a combination of antibody therapies, therapeutic vaccines and other antibody-based therapies in neurodegenerative diseases and other misfolded protein diseases, including Alzheimer's disease multi-system atrophy and amyotrophic lateral sclerosis. The company also plans to study other synuclein diseases, including Parkinson's disease and Lewy body dementia, frontotemporal lobe degeneration, progressive supranuclear palsy, corticobasal ganglia degeneration and schizophrenia. These diseases have a common biological cause — misfolded proteins that otherwise function normally, become toxic and kill neurons, leading to disease. ProMIS 'technology platform is an example of progress in drug discovery through computing power, computer discovery and artificial intelligence.

Company Financials

EPS

PMN has released its 2024 Q4 earnings. EPS was reported at -0.02, versus the expected -0.08, beating expectations. The chart below visualizes how PMN has performed over recent quarters, highlighting trends in earnings surprises.